News
-
-
PRESS RELEASE
PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSS
Bausch Health, Canada announces positive reimbursement recommendations for new acne treatment CABTREO, the first triple-combination topical therapy approved in Canada -
-
-
-
PRESS RELEASE
ACG Presidential Plenary to Highlight Analysis of Xifaxan(R) (rifaximin) Risk Reduction of Overt Hepatic Encephalopathy (OHE) Recurrence
Bausch Health's additional ACG presentation to focus on Xifaxan impact on OHE rehospitalizations and Plenvu bowel preparation efficacy at ACG 2024. Posters to share findings on treatments -
-
-
-
PRESS RELEASE
Bausch Health and Salix Survey Highlights Urgent Need for Improved Understanding of Liver Disease Across Healthcare Provider Disciplines as Prevalence of Cirrhosis Rises
Bausch Health Companies Inc. and Salix Pharmaceuticals release Liver Health Trends Report highlighting need for improved chronic liver disease care, education, and management
